Idaptiq Trials Inc. has successfully completed a private offering, raising a total of $2.79 million through the issuance of Simple Agreements for Future Equity (SAFEs). This significant funding event is crucial for the company as it seeks to advance its projects and expand its operations in the competitive technology landscape.

Founded in 2026 and based in Presque Isle, Michigan, Idaptiq Trials Inc. operates in the technology sector. The company is incorporated in Delaware and has a central index key (CIK) of 0002161388. The recent filing, dated November 2, 2026, indicates that this is the first offering for the company, which has not disclosed its revenue range.

The SEC filing reveals that the offering attracted 26 accredited investors, with no non-accredited investors participating. The total amount sold matches the total offering amount of $2.79 million, indicating a successful fundraising effort. Notably, the filing specifies that there were no sales commissions or finders' fees associated with this offering.

The impact of this funding could be significant for Idaptiq Trials Inc. as it positions itself for future growth. With the technology sector continually evolving, the company's ability to secure funding through SAFEs may inspire other startups in the industry to explore similar avenues for financing.

Looking ahead, the filing does not specify what the next steps will be for Idaptiq Trials Inc. However, the successful completion of this offering suggests that the company is on a path to utilize these funds effectively for its upcoming projects.